Literature DB >> 2244283

Bladder surface glycosaminoglycans is a human epithelial permeability barrier.

J D Lilly1, C L Parsons.   

Abstract

Transitional epithelium of the bladder has been known to be impermeable. The data reported herein suggest the principal barrier to permeability may be glycosaminoglycans (GAG) of the surface of the bladder. We examined the ability of surface GAG to prevent a small molecule, urea, from moving across the epithelium in humans. It appears that GAG provide a physical barrier which prevents small molecules from reaching the underlying tight junctions and cell membranes and, hence, are a major permeability barrier. Normal volunteers (27) had 100 milliliters of a 200 grams per liter urea solution placed into their bladders for 45 minutes. Net flow of urea from the bladder lumen was 5.1 per cent. Volunteers who were capable of completing the study (19) had protamine sulfate (5 milligrams per milliliter) instilled in the bladder for 15 minutes, then removed and a second urea study done. Urea loss was significantly higher at 22 per cent (p less than 0.02). A solution of heparin (2,000 units per milliliter) was instilled for 15 minutes followed by a third urea study and urea loss was reversed to 9 per cent. All volunteers experienced significant urinary urgency and discomfort after protamine treatment which were reduced by heparin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2244283

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  53 in total

Review 1.  Formation and maintenance of blood-urine barrier in urothelium.

Authors:  Mateja Erdani Kreft; Samo Hudoklin; Kristijan Jezernik; Rok Romih
Journal:  Protoplasma       Date:  2010-06-04       Impact factor: 3.356

Review 2.  Host-pathogen interactions in urinary tract infection.

Authors:  Greta R Nielubowicz; Harry L T Mobley
Journal:  Nat Rev Urol       Date:  2010-07-20       Impact factor: 14.432

3.  Desquamation of urinary bladder epithelial cells.

Authors:  K Jezernik
Journal:  Pflugers Arch       Date:  1996       Impact factor: 3.657

Review 4.  Interstitial cystitis.

Authors:  D R Erickson; M F Davies
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1998

5.  New concepts in interstitial cystitis.

Authors:  C L Parsons
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1997

6.  The complete functional recovery of chitosan-treated biomimetic hyperplastic and normoplastic urothelial models.

Authors:  Tanja Višnjar; Mateja Erdani Kreft
Journal:  Histochem Cell Biol       Date:  2014-08-27       Impact factor: 4.304

Review 7.  Urinary bladder, cystitis and nerve/urothelial interactions.

Authors:  Lori A Birder
Journal:  Auton Neurosci       Date:  2013-12-25       Impact factor: 3.145

8.  MicroRNAs may mediate the down-regulation of neurokinin-1 receptor in chronic bladder pain syndrome.

Authors:  Veronica Sanchez Freire; Fiona C Burkhard; Thomas M Kessler; Annette Kuhn; Annette Draeger; Katia Monastyrskaya
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

9.  Urinary glycosaminoglycan excretion in patients with primary nocturnal enuresis.

Authors:  Yasemin U Budak; Kağan Huysal; Atilla Guray
Journal:  Ital J Pediatr       Date:  2010-02-03       Impact factor: 2.638

Review 10.  Vesicoureteral reflux and the extracellular matrix connection.

Authors:  Fatima Tokhmafshan; Patrick D Brophy; Rasheed A Gbadegesin; Indra R Gupta
Journal:  Pediatr Nephrol       Date:  2016-05-02       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.